Jason E. Tester

Insider Reports History

Location
Irvine, CA
Signature
/s/ Leo Greenstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason E. Tester:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (right to buy) 10,000 $109,900 $10.99 15 Jun 2021 Direct

Insider Reports Filed by Jason E. Tester

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 15 Jun 2021 2 $0 4 Director, 10%+ Owner 17 Jun 2021, 19:26